# Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops

> **NCT00659555** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** pazopanib eye drops
- **DRUG:** Ketoconozole tablets

## Key facts

- **NCT ID:** NCT00659555
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-04
- **Primary completion:** 2008-05-10
- **Final completion:** 2008-05-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659555, "Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00659555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*